Literature DB >> 17504643

Spontaneous pain and brain activity in neuropathic pain: functional MRI and pharmacologic functional MRI studies.

Marwan N Baliki1, Paul Y Geha, A Vania Apkarian.   

Abstract

Functional brain imaging studies in chronic neuropathic pain patients have lagged far behind equivalent studies in acute pain. In the past few years, this trend has begun to shift. This article discusses the novel approach of studying brain activity for spontaneous pain and its modulation by pharmacologic manipulation. We argue that the approach provides a solid methodology for studying clinical (especially neuropathic) pain and patient populations, and moreover, that the latest results using this approach imply that distinct clinical chronic pain conditions seem to involve specific brain circuitry, which is also distinct from the brain activity commonly observed in acute pain.

Entities:  

Mesh:

Year:  2007        PMID: 17504643     DOI: 10.1007/s11916-007-0187-3

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  41 in total

Review 1.  Preclinical assessment of candidate analgesic drugs: recent advances and future challenges.

Authors:  S S Negus; T W Vanderah; M R Brandt; E J Bilsky; L Becerra; D Borsook
Journal:  J Pharmacol Exp Ther       Date:  2006-06-02       Impact factor: 4.030

Review 2.  Brain imaging findings in neuropathic pain.

Authors:  Paul Y Geha; A Vania Apkarian
Journal:  Curr Pain Headache Rep       Date:  2005-06

3.  Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia.

Authors:  Denis Ducreux; Nadine Attal; Fabrice Parker; Didier Bouhassira
Journal:  Brain       Date:  2006-01-24       Impact factor: 13.501

4.  Empathy examined through the neural mechanisms involved in imagining how I feel versus how you feel pain.

Authors:  Philip L Jackson; Eric Brunet; Andrew N Meltzoff; Jean Decety
Journal:  Neuropsychologia       Date:  2005-09-06       Impact factor: 3.139

5.  Pharmacological FMRI in the development of new analgesic compounds.

Authors:  Petra Schweinhardt; Chas Bountra; Irene Tracey
Journal:  NMR Biomed       Date:  2006-10       Impact factor: 4.044

6.  Regional mu opioid receptor regulation of sensory and affective dimensions of pain.

Authors:  J K Zubieta; Y R Smith; J A Bueller; Y Xu; M R Kilbourn; D M Jewett; C R Meyer; R A Koeppe; C S Stohler
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

Review 7.  Human brain mechanisms of pain perception and regulation in health and disease.

Authors:  A Vania Apkarian; M Catherine Bushnell; Rolf-Detlef Treede; Jon-Kar Zubieta
Journal:  Eur J Pain       Date:  2005-01-21       Impact factor: 3.931

8.  Empathy and judging other's pain: an fMRI study of alexithymia.

Authors:  Yoshiya Moriguchi; Jean Decety; Takashi Ohnishi; Motonari Maeda; Takeyuki Mori; Kiyotaka Nemoto; Hiroshi Matsuda; Gen Komaki
Journal:  Cereb Cortex       Date:  2006-12-05       Impact factor: 5.357

9.  Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil.

Authors:  Richard G Wise; Richard Rogers; Deborah Painter; Susanna Bantick; Alexander Ploghaus; Pauline Williams; Garth Rapeport; Irene Tracey
Journal:  Neuroimage       Date:  2002-08       Impact factor: 6.556

10.  Pain catastrophizing and neural responses to pain among persons with fibromyalgia.

Authors:  R H Gracely; M E Geisser; T Giesecke; M A B Grant; F Petzke; D A Williams; D J Clauw
Journal:  Brain       Date:  2004-02-11       Impact factor: 13.501

View more
  12 in total

1.  The analgesic effect of pregabalin in patients with chronic pain is reflected by changes in pharmaco-EEG spectral indices.

Authors:  Carina Graversen; Søren S Olesen; Anne E Olesen; Kristoffer Steimle; Dario Farina; Oliver H G Wilder-Smith; Stefan A W Bouwense; Harry van Goor; Asbjørn M Drewes
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

Review 2.  How close are we in utilizing functional neuroimaging in routine clinical diagnosis of neuropathic pain?

Authors:  David Borsook; Lino Becerra
Journal:  Curr Pain Headache Rep       Date:  2011-06

Review 3.  Neuroimaging of neuropathic pain: review of current status and future directions.

Authors:  Soha Alomar; Mohamad Bakhaidar
Journal:  Neurosurg Rev       Date:  2016-12-14       Impact factor: 3.042

Review 4.  [Pharmacological fMRI : new possibilities for assessing the efficacy of analgesic agents].

Authors:  J Lorenz; W Auffermann
Journal:  Schmerz       Date:  2010-04       Impact factor: 1.107

5.  fMRI evidence of degeneration-induced neuropathic pain in diabetes: enhanced limbic and striatal activations.

Authors:  Ming-Tsung Tseng; Ming-Chang Chiang; Chi-Chao Chao; Wen-Yih I Tseng; Sung-Tsang Hsieh
Journal:  Hum Brain Mapp       Date:  2012-04-21       Impact factor: 5.038

6.  Cortical disinhibition occurs in chronic neuropathic, but not in chronic nociceptive pain.

Authors:  Peter Schwenkreis; Andrea Scherens; Anne-Kathrin Rönnau; Oliver Höffken; Martin Tegenthoff; Christoph Maier
Journal:  BMC Neurosci       Date:  2010-06-11       Impact factor: 3.288

7.  Chronic pain following spinal cord injury.

Authors:  Radi Masri; Asaf Keller
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

8.  Zona incerta: a role in central pain.

Authors:  Radi Masri; Raimi L Quiton; Jessica M Lucas; Peter D Murray; Scott M Thompson; Asaf Keller
Journal:  J Neurophysiol       Date:  2009-04-29       Impact factor: 2.714

Review 9.  Electrophysiology as a tool to unravel the origin of pancreatic pain.

Authors:  Dina Lelic; Søren Schou Olesen; Carina Graversen; Christina Brock; Massimiliano Valeriani; Asbjørn Mohr Drewes
Journal:  World J Gastrointest Pathophysiol       Date:  2014-02-15

10.  Central pain processing in chronic chemotherapy-induced peripheral neuropathy: a functional magnetic resonance imaging study.

Authors:  Elaine G Boland; Dinesh Selvarajah; Mike Hunter; Yousef Ezaydi; Solomon Tesfaye; Sam H Ahmedzai; John A Snowden; Iain D Wilkinson
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.